Provider review
MyFastRx review
The clearest flat-dose promise on this site, and flat is the wrong direction for you.
One price at every dose, stated twice and with a time horizon on it. That means a quarter dose costs what a full dose costs. The figure in the nav is a first-month code price, not the rate that recurs.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
MyFastRx
$139/mo semaglutide, $199 tirzepatide
- Vs median
- $30/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
A quarter dose costs exactly what a full dose costs here, and MyFastRx is more explicit about it than anyone — same price at any dose, no dose-stage upcharges, from week one through month six and beyond, plus a second statement that approved dose changes carry no extra cost. If you are taking less to spend less, that is the shape working against you, and the gap is drug you buy and never use. Credit where it is earned. It labels its prepay figures as equivalents and says the money is taken up front, rather than passing a prepay rate off as a monthly price. It offers a genuinely non-recurring single month. And it discloses that the introductory price needs a code and is new-customers-only. Two things still cost you. The figure in the nav is that first month, and the rate that recurs is about double it. And no milligram figure sits behind any price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are starting low and expect to climb, and want the price to hold when you do.
- You want one month with no subscription behind it.
- You want prepay figures labeled as equivalents rather than dressed up as monthly rates.
- You want the introductory offer's conditions stated before you buy, not after.
Look elsewhere if
- You are taking less to spend less. This charges you the full rate for a fraction of the drug.
- You are working from the figure in the nav. That is the first month, with a code, for new customers only.
- You want to check the flat promise against a dose range. No milligram figure is published.
- You want the dispensing pharmacy named, or your state confirmed before you order.
What it actually costs
Price as published
Compounded semaglutide $139/mo standing and compounded tirzepatide $199/mo standing · first month $69 semaglutide and $129 tirzepatide — "$70 introductory savings applied to the first month", "First-month pricing applies with code MY70 for new customers only" · semaglutide prepay rungs 3 months $297 billed upfront ($99/mo equivalent), 6 months $534 upfront ($89/mo), 12 months $948 upfront ($79/mo), and every total divides exactly · the single-month option states "No subscription or automatic billing" · the nav headline "Semaglutide · From $69" is the coded first-month price, disclosed on the same card as "Then $139/mo" · no tirzepatide prepay ladder is published on the semaglutide page
- Vs median
- $30/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. The row records the flat structure declared twice in the provider's own words, once naming the specific practice it rules out and once confirming that approved dose changes carry no extra charge, covering both molecules. The tier describes the dose-to-price relationship and not the advertised number: the headline figure is a coded first-month price for new customers, and the prepay rungs are taken as a single up-front charge, which the site labels honestly. No milligram figure is published against any price, so the flat claim is credible but unspecified as to range.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Flat at every dose
- Price last updated
- August 2026
What it does well
- The most explicit flat-dose language anywhere here — it names the specific failure mode it rules out and puts a horizon on it: "Same price at any dose, with no membership fees, no dose-stage upcharges. No hidden fees. Your price stays the same from week one through month six and beyond"
- Says it a second, independent way: "Approved dose changes are included at no additional cost"
- Uses "/mo equivalent" and "billed upfront" rather than passing a prepay rate off as a monthly price
- Offers a genuinely non-recurring single month: "No subscription or automatic billing"
- Discloses that the introductory price requires code MY70 and is new-customers-only
- Publishes a like-for-like comparison of both molecules with intro and standing rates side by side: "$69 first month · $139/mo regular" against "$129 first month · $199/mo regular"
Pharmacy, labs and oversight
MyFastRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What MyFastRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsOne price at every dose, so the bill is knowable before you titrate.
- Published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
MyFastRx sells compounded semaglutide and compounded tirzepatide as weekly injections, priced openly with a standing monthly rate, a coded first-month price and a semaglutide prepay ladder. It states its flat-dose policy twice, once naming the specific practice it rules out and once confirming that approved dose changes carry no extra cost. Prepay figures are labeled "/mo equivalent" and "billed upfront" rather than presented as monthly rates, and a single-month option carries no subscription behind it. No compounding pharmacy is named and no milligram figure appears against any price.
The honest cons
ONE PRICE AT EVERY DOSE IS THE STRUCTURE THIS SITE EXISTS TO FLAG. "Same price at any dose... no dose-stage upcharges" means a patient deliberately holding a quarter dose pays the identical $139 as one at the top of the range
- THE "FROM $69" IN THE NAV IS THE FIRST MONTH ONLY, requires code MY70 and is new-customers-only; the standing rate is $139/mo, disclosed on the same card as "Then $139/mo"
- NO MILLIGRAM FIGURE IS PUBLISHED AGAINST ANY PRICE, so the flat promise cannot be checked against a dose range
- The prepay rungs take the whole sum in one charge — $948 for the 12-month plan, labeled "billed upfront"
- No tirzepatide prepay ladder is published on the semaglutide page
- No compounding pharmacy is named
- States served are not published
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
MyFastRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#92 of 373
Ordered with the companies that pay us first, and MyFastRx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Low dose vs full dose
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.